115 related articles for article (PubMed ID: 3902748)
1. Does cyclosporine influence the results of cadaver retransplantation?
Flechner SM; Lorber MI; Kerman RH; Van Buren CT; Wideman C; Kahan BD
Hum Immunol; 1985 Nov; 14(3):305-13. PubMed ID: 3902748
[TBL] [Abstract][Full Text] [Related]
2. Kidney retransplantation in the cyclosporine era.
Stratta RJ; Oh CS; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for second renal allografts immunosuppressed with cyclosporine.
Almond PS; Matas AJ; Gillingham K; Troppmann C; Payne W; Dunn D; Sutherland D; Najarian JS
Transplantation; 1991 Aug; 52(2):253-8. PubMed ID: 1871798
[TBL] [Abstract][Full Text] [Related]
4. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
Kerman RH; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
Martin DC; Tertzakian G; Ruzics E
J Urol; 1990 May; 143(5):900-1. PubMed ID: 2329602
[TBL] [Abstract][Full Text] [Related]
6. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
[TBL] [Abstract][Full Text] [Related]
7. Results with cyclosporine in renal transplantation in patients who have lost two previous allografts.
Ladowski JS; Rosenthal JT; Taylor RJ; Starzl TE; Carpenter B; Gordon R; Iwatsuki S; Hakala TR
Surg Gynecol Obstet; 1987 Jun; 164(6):553-6. PubMed ID: 3296255
[TBL] [Abstract][Full Text] [Related]
8. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
9. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
10. Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches.
Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
Transplantation; 1985 Dec; 40(6):615-9. PubMed ID: 3907031
[TBL] [Abstract][Full Text] [Related]
11. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
[TBL] [Abstract][Full Text] [Related]
12. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
[TBL] [Abstract][Full Text] [Related]
13. Use of cyclosporine in pediatric renal transplant recipients.
Conley SB; Flechner SM; Rose G; Van Buren CT; Brewer E; Kahan BD
J Pediatr; 1985 Jan; 106(1):45-9. PubMed ID: 3880820
[TBL] [Abstract][Full Text] [Related]
14. Short-term and long-term function of cadaveric kidneys from pediatric donors in recipients treated with cyclosporine.
Smith AY; Van Buren CT; Lewis RM; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):360-7. PubMed ID: 3278429
[TBL] [Abstract][Full Text] [Related]
15. The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant patients.
Cicciarelli J; Terasaki PI; Mickey MR
Transplantation; 1987 May; 43(5):636-40. PubMed ID: 3554654
[TBL] [Abstract][Full Text] [Related]
16. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation.
Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
Transplantation; 1987 Feb; 43(2):225-8. PubMed ID: 3544380
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.
Canadian Multicentre Transplant Study Group
N Engl J Med; 1986 May; 314(19):1219-25. PubMed ID: 2871486
[TBL] [Abstract][Full Text] [Related]
18. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
Reinsmoen NL; Matas AJ
Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipients.
Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
Transplantation; 1987 Jan; 43(1):65-70. PubMed ID: 3541326
[TBL] [Abstract][Full Text] [Related]
20. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry M; Ferguson RM
Transplantation; 1987 Jan; 43(1):85-90. PubMed ID: 3541330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
